Anti-C1q antibodies in systemic lupus erythematosus.

A-M Orbai, Lennart Truedsson, Gunnar Sturfelt, Ola Nived, H Fang, Gs Alarcón, C Gordon, Jt Merrill, Pr Fortin, In Bruce, DA Isenberg, Dj Wallace, R Ramsey-Goldman, S-C Bae, Jg Hanly, J Sanchez-Guerrero, Ae Clarke, Cb Aranow, S Manzi, Mb UrowitzDd Gladman, Kc Kalunian, Mi Costner, Vp Werth, A Zoma, S Bernatsky, G Ruiz-Irastorza, Ma Khamashta, S Jacobsen, Jp Buyon, P Maddison, Ma Dooley, Rf Van Vollenhoven, E Ginzler, T Stoll, C Peschken, Jl Jorizzo, Jp Callen, Ss Lim, Bj Fessler, M Inanc, Dl Kamen, A Rahman, K Steinsson, Ag Franks, L Sigler, S Hameed, N Pham, R Brey, Mh Weisman, G McGwin, Ls Magder, M Petri

Research output: Contribution to journalArticlepeer-review

84 Citations (SciVal)


Anti-C1q has been associated with systemic lupus erythematosus (SLE) and lupus nephritis in previous studies. We studied anti-C1q specificity for SLE (vs rheumatic disease controls) and the association with SLE manifestations in an international multicenter study.
Original languageEnglish
Pages (from-to)42-49
Issue number1
Publication statusPublished - 2015

Subject classification (UKÄ)

  • Microbiology in the medical area
  • Immunology in the medical area
  • Rheumatology and Autoimmunity


Dive into the research topics of 'Anti-C1q antibodies in systemic lupus erythematosus.'. Together they form a unique fingerprint.

Cite this